Eurofins Cerep SAS (ALECR) | Financial Analysis & Statements
Eurofins Cerep SAS | Small-cap | Healthcare
Eurofins Cerep SAS | Small-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
40.5M
Gross Profit
17.5M
43.14%
Operating Income
4.7M
11.58%
Net Income
7.2M
17.68%
Balance Sheet Metrics
Total Assets
84.1M
Total Liabilities
12.3M
Shareholders Equity
71.7M
Debt to Equity
0.17
Cash Flow Metrics
Revenue & Profitability Trend
Eurofins Cerep SAS Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 40.5M | 44.1M | 47.6M | 41.6M | 32.7M |
| Cost of Goods Sold | 23.0M | 23.9M | 24.0M | 20.8M | 16.8M |
| Gross Profit | 17.5M | 20.2M | 23.6M | 20.8M | 15.8M |
| Operating Expenses | 919.6K | 1.7M | 1.6M | 1.4M | 3.3M |
| Operating Income | 4.7M | 6.4M | 11.7M | 10.1M | 5.6M |
| Pre-tax Income | 6.5M | 7.1M | 11.1M | 9.4M | 5.1M |
| Income Tax | -676.1K | -516.3K | -420.5K | -482.6K | -431.4K |
| Net Income | 7.2M | 7.6M | 11.5M | 9.8M | 5.6M |
| EPS (Diluted) | - | €1,514.43 | €2,284.78 | €1,951.38 | €1,105.73 |
Income Statement Trend
Eurofins Cerep SAS Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 72.7M | 66.3M | 58.5M | 48.3M | 37.6M |
| Non-Current Assets | 11.4M | 13.0M | 12.5M | 11.4M | 8.5M |
| Total Assets | 84.1M | 79.2M | 71.0M | 59.7M | 46.1M |
| Liabilities | |||||
| Current Liabilities | 10.5M | 12.8M | 12.3M | 11.7M | 8.0M |
| Non-Current Liabilities | 1.9M | 1.8M | 1.8M | 2.7M | 2.9M |
| Total Liabilities | 12.3M | 14.6M | 14.1M | 14.4M | 10.9M |
| Equity | |||||
| Total Shareholders Equity | 71.7M | 64.6M | 56.9M | 45.4M | 35.1M |
Balance Sheet Composition
Eurofins Cerep SAS Cash Flow Statement
No cash flow data available.
Eurofins Cerep SAS Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
14.33
Price to Sales
2.57
Profitability Ratios
Profit Margin
17.67%
Operating Margin
13.38%
Return on Equity
10.49%
Return on Assets
3.22%
Financial Health
Current Ratio
6.94
Debt to Equity
0.46
Beta
0.44
Per Share Data
EPS (TTM)
€1,437.88
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| alecr | 103.9M | 14.33 | - | 10.49% | 17.67% | 0.46 |
| Lumibird S.A | 353.3M | 61.73 | 1.78 | 2.91% | 2.71% | 81.34 |
| Klea Holding | 53.9M | 17.87 | 1.92 | 5.35% | 8.14% | 21.13 |
| Predilife S.A | 13.9M | - | - | -4,653.75% | 97.76% | -1.16 |
| bioMérieux S.A | 14.2B | 32.96 | 3.37 | 10.68% | 10.86% | 11.65 |
| Eurofins Scientific | 10.6B | 28.48 | 2.56 | 7.71% | 5.85% | 67.05 |
Financial data is updated regularly. All figures are in the company's reporting currency.